Patents by Inventor Joaquim Carlos NETO MURTA

Joaquim Carlos NETO MURTA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Non-invasive ocular drug delivery insert technology
    Patent number: 11642311
    Abstract: Non-invasive Ocular Drug Delivery Insert Technology. The invention concerns an ocular insert which is a new biocompatible polymer-based controlled drug delivery system (CDDS) applicable to a variety of drugs and other compounds for the treatment of different ocular pathologies. This ocular insert allows releasing of at least one drug under suitable concentration levels during suitable periods of time. The device may be inserted in the lower or upper fornix conjunctiva, in a non-invasive way, meaning that the patient will be able to place the device himself, without intervention of medical specialized staff. The insert of the invention will release the drug in such a controlled rate that will allow the drug release up to 300 days by either a “Fickian” or a linear profile according to the intend purpose or pathology.
    Type: Grant
    Filed: February 10, 2017
    Date of Patent: May 9, 2023
    Assignee: UNIVERSIDADE DE COIMBRA
    Inventors: Marcos João Mota Leite Machado Mariz, Paula Cristina Nunes Ferreira Calvinho, Maria Helena Mendes Gil, Joaquim Carlos Neto Murta
  • NON-INVASIVE OCULAR DRUG DELIVERY INSERT TECHNOLOGY
    Publication number: 20190046434
    Abstract: Non-invasive Ocular Drug Delivery Insert Technology. The invention concerns an ocular insert which is a new biocompatible polymer-based controlled drug delivery system (CDDS) applicable to a variety of drugs and other compounds for the treatment of different ocular pathologies. This ocular insert allows releasing of at least one drug under suitable concentration levels during suitable periods of time. The device may be inserted in the lower or upper fornix conjunctiva, in a non-invasive way, meaning that the patient will be able to place the device himself, without intervention of medical specialized staff. The insert of the invention will release the drug in such a controlled rate that will allow the drug release up to 300 days by either a “Fickian” or a linear profile according to the intend purpose or pathology.
    Type: Application
    Filed: February 10, 2017
    Publication date: February 14, 2019
    Inventors: Marcos João MOTA LEITE MACHADO MARIZ, Paula Cristina NUNES FERREIRA CALVINHO, Maria Helena MENDES GIL, Joaquim Carlos NETO MURTA